JPRN-UMIN000022516已完成未知
The potential role of BTMs in the prediction of hypocalcemia induced by denosumab in patients with bone metastases. - The potential role of BTMs in the prediction of hypocalcemia induced by denosumab in patients with bone metastases.
Department of Orthopaedic Surgery, Showa University School of Medicine, Tokyo, Japan0 个研究点目标入组 50 人开始时间: 2016年5月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
Ishikawa K, Nagai T, Tuchiya K, et al. High bone turnover status as a risk factor for symptomatic hypocalcemia following denosumab treatment in patients with osteoporosis. Clin Interv Aging. 8;13:1929-1934.2018.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded from the study if they had (1)contraindicate factors (2)hyperparathyroidism or under the pregnacy. (3)adjusted baseline serum calcium concentrations above or below the normal range in our laboratory.
研究者
相似试验
招募中
不适用
Dynamics in Bone Turnover Markers During and After Short-term Glucocorticoid Treatment in Patients With an Inflammatory Joint DiseaseOsteoporosisOsteoporosis, Steroid InducedInflammatory RheumatismNCT06395883Diakonhjemmet Hospital160
进行中（未招募）
1 期
Bone turnover markers as predictors of treatment break outcomeMedDRA version: 19.0 Level: LLT Classification code 10031289 Term: Osteoporosis, unspecified System Organ Class: 100000004859OsteoporosisEUCTR2016-003110-27-DKBente Lomholt Langdahl, Dept. of Endocrinology and Internal Medicine, Aarhus University Hospital140
已完成
不适用
Serum Biomarkers in Diagnosis of MesotheliomaMesotheliomaNCT02029105Eskisehir Osmangazi University230
已完成
不适用
Bone Architectural Parameters in Postmenopausal Women Affected With Primary HyperparathyroidismBone DiseasePrimary HyperparathyroidismNCT02539498Assistance Publique - Hôpitaux de Paris82
Unknown
不适用
Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner SyndromeTurner SyndromeNCT00625001University of Aarhus54